NEJM articles on Parkinson's: Visit NEJM... - Cure Parkinson's

Cure Parkinson's

26,039 members27,332 posts

NEJM articles on Parkinson's

mhberman profile image
1 Reply

Visit NEJM.org

Update Geriatrics/Aging

A Summary of Recently Published Activity

ORIGINAL ARTICLE

Trial of Prasinezumab in Early-Stage Parkinson’s Disease

G. Pagano and Others

N Engl J Med 387:421, August 4, 2022

digital object - quick takeQuick Take

Trial of Cinpanemab in Early Parkinson’s Disease

A.E. Lang and Others

N Engl J Med 387:408, August 4, 2022

digital object - quick takeQuick Take

EDITORIAL

Monoclonal Antibody Therapy in Parkinson’s Disease — The End?

A. Whone

N Engl J Med 387:466, August 4, 2022

Written by
mhberman profile image
mhberman
To view profiles and participate in discussions please or .
1 Reply
Boscoejean profile image
Boscoejean

clinicaltrials.gov/ct2/show...

Inclusion Criteria:

Diagnosis of idiopathic PD based on MDS criteria with bradykinesia plus one of the other cardinal signs of PD (resting tremor, rigidity), without any other known or suspected cause of parkinsonism

On symptomatic PD medication, with stable doses for at least 3 months prior to baseline

A diagnosis of PD for at least 3 months to maximum 3 years at screening

MDS-UPDRS Part IV score of 0 at screening and prior to randomization

Hoehn and Yahr (H&Y) Stage I or II in OFF medication state at screening and prior to randomization

Dopamine transporter imaging with single photon emission computed tomography (DaT-SPECT) imaging consistent with dopamine transporter deficit, as assessed by the central reader

No anticipated changes in PD medication from baseline throughout the study duration based on clinical status during screening

Willingness and ability to use a smartphone application to measure PD-related symptoms for the duration of the study

Willingness and ability to wear a smartwatch to measure PD-related motor signs

Not what you're looking for?

You may also like...

Lithium for Parkinson's Book Coming in October

Blood-based Therapeutic Targets in Parkinson's Disease\\" trial...

Virtual Reality Training Improves Balance for Patients With Parkinson Disease

Meta-Regression of a Randomized Controlled Trial 2022...

degenerating Parkinson or Parkinson +

Major Deal Pushes Parkinson's Vaccine Further in Testing

people with Parkinson’s. Please donate today to keep critical projects moving forward as quickly as...

Vascular Parkinsonism